Paranoia, turmoil and backlash: Inside the FDA under Marty Makary
While no immediate ouster is planned, people familiar with the matter who requested anonymity to discuss personnel matters say one more high-profile misstep could put Mark Makary's job at risk.
Original Source
Read the full article at Seattletimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.